Pharmaceuticals

Global Oncology Precision Medicine Market 2026 transforming cancer care with data-driven treatment strategies

March 23, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Oncology Precision Medicine Market At The End Of The 2026–2030 Forecast Period?

The oncology precision medicine market has experienced substantial expansion in recent years. Its valuation is projected to increase from $125.14 billion in 2025 to $141.22 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.9%. This historical growth can be linked to factors such as the limited availability of genomic testing, a reliance on standard chemotherapy protocols, the increasing prevalence of cancer, the early evolution of molecular diagnostics, and the adoption of hospital-based oncology research programs.

The oncology precision medicine market is projected to experience substantial expansion over the upcoming years. This market is set to reach $226.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.5%. Key drivers for this anticipated growth include progress in CAR-T and gene therapies, an increase in targeted kinase and immune checkpoint inhibitors, greater investments in precision oncology research, the incorporation of bioinformatics and AI into clinical decision support, and the expansion of clinical trials guided by biomarkers. Notable trends identified for the projection period encompass a growing uptake of personalized cancer treatments, enhanced utilization of companion and molecular diagnostics, an expansion in liquid biopsy and next-generation sequencing assays, the proliferation of targeted therapeutics and monoclonal antibodies, and a heightened emphasis on patient stratification based on biomarkers.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25853&type=smp

What Primary Drivers Are Shaping The Development Of The Oncology Precision Medicine Market?

The oncology precision medicine market is anticipated to expand due to the increasing incidence of cancer. Cancer involves the uncontrolled proliferation of aberrant cells, which can disseminate throughout the body and impair physiological functions. This rise in cancer cases stems from aging demographics, where extended lifespans contribute to deoxyribonucleic acid (DNA) mutation build-up, less efficient repair mechanisms, persistent inflammation associated with aging, reduced immune monitoring, and tissue environments that increasingly favor tumor development. Oncology precision medicine offers benefits for cancer patients by tailoring treatments according to each tumor’s distinct genetic profile, thereby enhancing efficacy and minimizing adverse reactions. As an illustration, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in February 2024 that the projected 20 million new cancer cases in 2022 are predicted to surge by 77% to exceed 35 million cases by 2050. Consequently, the escalating occurrence of cancer acts as a key driver for the expansion of the oncology precision medicine market.

What Segment Types Make Up The Oncology Precision Medicine Market?

The oncology precision medicine market covered in this report is segmented –

1) By Product Type: Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs

2) By Technology: Genomics, Proteomics, Bioinformatics, Other Technologies

3) By Biomarker Types: Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types

4) By Applications: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications

5) By End-Users: Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Diagnostics: Companion Diagnostics, Molecular Diagnostics, Liquid Biopsy, Imaging Diagnostics, Next-Generation Sequencing Assays

2) By Therapeutics: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

3) By Inhibitor Drugs: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

4) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, Radiolabeled Antibodies

5) By Cell And Gene Therapy: CAR-T Cell Therapies, T-Cell Receptor (TCR) Therapies, Tumor-Infiltrating Lymphocyte (TIL) Therapies, Oncolytic Viral Therapies, Gene Editing And Replacement Therapies

6) By Antiviral And Anti-Retroviral Drugs: Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Entry Inhibitors, Antiviral Agents Targeting Virus-Related Cancers

Which Market Trends Are Creating New Opportunities In The Oncology Precision Medicine Market?

Leading companies in the oncology precision medicine market are concentrating on developing novel solutions, such as molecular tumor board initiatives, to foster multidisciplinary collaboration and enhance personalized treatment planning. Molecular tumor boards are multidisciplinary teams of experts who review and interpret complex genetic and molecular test results to recommend personalized cancer treatment strategies. For instance, in April 2025, McKesson Corporation, a US-based healthcare services and information technology company, launched the Precision Care Companion initiative to support biomarker-driven cancer care by providing education, technology enhancements, and operational assistance to oncology practices. This comprehensive program unites physicians, clinical staff, business leaders, and pharmaceutical partners to create a collaborative environment that speeds the integration of advanced genomic testing and targeted therapies, ultimately helping providers deliver more personalized and effective cancer treatments while improving patient outcomes.

Who Are The Key Players Driving Competition In The Oncology Precision Medicine Market?

Major companies operating in the oncology precision medicine market are Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc.

Read the full oncology precision medicine market report here:

https://www.thebusinessresearchcompany.com/report/oncology-precision-medicine-global-market-report

How Does The Oncology Precision Medicine Market Perform Across Major Global Regions?

North America was the largest region in the oncology precision medicine market in 2025. The regions covered in the oncology precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oncology Precision Medicine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25853&type=smp

Browse Through More Reports Similar to the Global Oncology Precision Medicine Market 2026, By The Business Research Company

Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795